Sonoma Pharmaceuticals, Inc. — Director's Dealing 2008

Mar 13, 2008

SEC Form 4/A — Form 4/A

Issuer: Oculus Innovative Sciences, Inc. (OCLS)
CIK: 0001367083
Period of Report: 2008-03-07

Reporting Person: Alimi Hojabr (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-03-07	Common Stock	S	15000	$5.36	Disposed	981250	Direct

Footnotes

F1: Amendment filed to correct Transaction Code